These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12801341)

  • 21. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
    Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
    Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
    Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Locating the sentinel node in breast cancer by gamma probe and staining agent. Preliminary study].
    Vázquez Forner C; Giménez Climent J; Fliquete Peris MV; Fuster Diana C; Más Arcas C; Vázquez Albaladejo C
    Rev Esp Med Nucl; 2000 Jun; 19(3):207-10. PubMed ID: 11062084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The feasibility and accuracy of the sentinel lymph node biopsy for breast carcinoma.
    Jaderborg JM; Harrison PB; Kiser JL; Maynard SL
    Am Surg; 1999 Aug; 65(8):699-703; discussion 704-5. PubMed ID: 10432076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
    Crossin JA; Johnson AC; Stewart PB; Turner WW
    Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
    Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
    Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of lymphoscintigraphic mapping with Tc-99m human serum albumin and tin colloid in sentinel lymph node biopsy in breast cancer.
    Kim R; Osaki A; Kojima J; Toge T
    Int J Oncol; 2001 Nov; 19(5):991-6. PubMed ID: 11604999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial experience in a cancer hospital in Nepal with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer.
    Lamichhane N; Pradhan M; Neupane PR; Shrestha BM; Dhakal HP; Thakur BK; Cox CE
    Nepal Med Coll J; 2007 Mar; 9(1):22-6. PubMed ID: 17593673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer.
    Radovanovic Z; Golubovic A; Plzak A; Stojiljkovic B; Radovanovic D
    Eur J Surg Oncol; 2004 Nov; 30(9):913-7. PubMed ID: 15498633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between one day and two days protocols for sentinel node mapping of breast cancer patients.
    Ali J; Alireza R; Mostafa M; Naser FM; Bahram M; Ramin S
    Hell J Nucl Med; 2011; 14(3):313-5. PubMed ID: 22087458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radio-guided sentinel lymph node biopsy using periareolar injection technique for patients with early breast cancer.
    Yen RF; Kuo WH; Lien HC; Chen TH; Jan IS; Wu YW; Wang MY; Chang KJ; Huang CS
    J Formos Med Assoc; 2007 Jan; 106(1):44-50. PubMed ID: 17282970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy.
    Feldman SM; Krag DN; McNally RK; Moor BB; Weaver DL; Klein P
    J Am Coll Surg; 1999 Mar; 188(3):248-54. PubMed ID: 10065813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients.
    Canavese G; Gipponi M; Catturich A; Vecchio C; Tomei D; Nicoló G; Carli F; Spina B; Bonelli L; Villa G; Buffoni F; Bianchi P; Agnese A; Mariani G
    J Surg Oncol; 2001 Jun; 77(2):81-7; discussion 88. PubMed ID: 11398158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
    Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
    Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery.
    Canavese G; Gipponi M; Catturich A; Di Somma C; Vecchio C; Rosato F; Percivale P; Moresco L; Nicolò G; Spina B; Villa G; Bianchi P; Badellino F
    J Surg Oncol; 2000 May; 74(1):61-8. PubMed ID: 10861612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.